RRMS
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GENESIS PharmaDimethyl Fumarate
Clinical Trials (1)
Total enrollment: 455 patients across 1 trials
Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece
Start: Sep 2016Est. completion: Apr 2020455 patients
N/ACompleted
Related Jobs
Regional Business Director, (West Region), Immunology
Waltham, MA
3d ago
$187K - $234K/yr
Regional Business Director, (Southeast Region), Immunology
Waltham, MA
3d ago
$187K - $234K/yr
Regional Business Director, (South Central Region), Immunology
Waltham, MA
3d ago
$187K - $234K/yr
Regional Business Director, (Northeast Region), Immunology
Waltham, MA
3d ago
$187K - $234K/yr
Regional Business Director, (Midwest Region), Immunology
Waltham, MA
3d ago
$187K - $234K/yr
Senior Manager/Associate Director, Program Management
1w ago
$185K - $215K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.